Inspira Technologies Oxy B.H.N. Ltd.

IINN

IL0011715781

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-15 pm EDT			5-day change	1st Jan Change
2.25 ^USD	+3.21%		+7.66%	+112.26%

May. 02	Inspira? Announces Start of Production of the Inspira? Art100	CI
Apr. 17	Inspira Technologies OXY B.H.N. Ltd Signs Collaboration Term Sheet with the Beilinson Hospital in Israel for the Evaluation of Its Proprietary INSPIRA ART100 device in Organ Transplant Procedures	CI

Inspira Technologies Oxy B.H.N. Ltd. Terminates the Employment Agreement with Udi Nussinovitch as Chief Scientific Officer

December 16, 2021 at 04:01 pm EST

On December 12, 2021, Inspira Technologies Oxy B.H.N. Ltd. terminated the employment agreement with Udi Nussinovitch, the Company's Chief Scientific Officer, effective immediately.

Latest news about Inspira Technologies Oxy B.H.N. Ltd.

Inspira? Announces Start of Production of the Inspira? Art100	May. 02	CI
Inspira Technologies OXY B.H.N. Ltd Signs Collaboration Term Sheet with the Beilinson Hospital in Israel for the Evaluation of Its Proprietary INSPIRA ART100 device in Organ Transplant Procedures	Apr. 17	CI
Inspira, Beilinson Hospital Collaborate on Organ Transplant Device Evaluation	Apr. 16	MT
Inspira?? and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth Causes Bloodstream Infections	Apr. 10	CI
Inspira? Technologies Oxy B.H.N. Ltd. Announces Program to Pioneer the Applicable Use of the INSPIRA? ART100 Device for an Artificial Womb	Apr. 03	CI
Inspira Technologies Oxy B.H.N. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Inspira Technologies OXY B.H.N. Ltd. Announces AMAR Regulatory Submission of the INSPIRA? ART100, to Enter the Southeast Asia and South American Markets	Mar. 18	CI
Inspira Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator	Mar. 12	CI
Inspira Technologies Oxy B.H.N. Ltd. Plans to Report the Primary Results for A Core Blood Oxygenation Technology Within Days	Mar. 04	CI
Inspira Technologies Oxy B.H.N. Ltd. Announces Approval from the U.S. Food & Drug Administration for its INSPIRA ART100 in the First Half of 2024	Feb. 27	CI
Inspira Technologies OXY B.H.N. Ltd. Introduces High-End Platform for Bio-Mimicking Blood parameters for Development and Testing of Core Technologies	Feb. 22	CI
Sector Update: Health Care Stocks Gain Late Afternoon	Feb. 14	MT
Sector Update: Health Care Stocks Rise in Afternoon Trading	Feb. 14	MT
Sector Update: Health Care	Feb. 14	MT
Inspira Gets US Patent Approval for Orbiting Blood Oxygenation Delivery System; Shares Rise	Feb. 14	MT
Inspiratm Technologies OXY B.H.N. Ltd. Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System	Feb. 14	CI
Inspira? Technologies Collaborates with Shamir Medical Center	Feb. 08	CI
Inspira? Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 Inspira? Art Devices	Jan. 30	CI
Inspira Technologies Oxy B.H.N. Ltd. Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for A New Disposable Perfusion Market Opportunity	Jan. 09	CI
Inspira Technologies Oxy B.H.N. Ltd. Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA? ART100 Device	Jan. 02	CI
Inspira Technologies Closes $3.88 Million Offering	Dec. 29	MT
Sector Update: Health Care Stocks Stronger Late Afternoon	Dec. 26	MT
Sector Update: Health Care	Dec. 26	MT
Inspira Technologies Shares Rise After Promising Results for Blood Sensor; Raises $3.9 Million via Offering	Dec. 26	MT
Inspira Technologies OXY BHN Ltd. Announces 95% Accuracy Results for HYLA?? Blood Sensor, Planning FDA Submission for Clearance in 2024	Dec. 26	CI

Chart Inspira Technologies Oxy B.H.N. Ltd.

Duration

Period

Chart Inspira Technologies Oxy B.H.N. Ltd.

More charts

Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-15 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.25 USD

Average target price

13 USD

Spread / Average Target

+477.78%

Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Monitoring Systems

	1st Jan change	Capi.
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.	+112.26%	38.91M
IRHYTHM TECHNOLOGIES, INC.	-6.03%	3.13B
EKF DIAGNOSTICS HOLDINGS PLC	+5.53%	188M
MEDIANA CO.,LTD	-14.58%	84.35M
NEUROTECH INTERNATIONAL LIMITED	+13.04%	51M
PULSENMORE LTD.	-52.90%	50.99M

Medical Monitoring Systems